VOYA Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $670K | Sell |
3,356
-91
| -3% | -$18K | ﹤0.01% | 1608 |
|
|
2025
Q4 | $652K | Hold |
3,447
| – | – | ﹤0.01% | 1637 |
|
|
2025
Q3 | $611K | Sell |
3,447
-1,729
| -33% | -$257K | ﹤0.01% | 1670 |
|
|
2025
Q2 | $588K | Buy |
5,176
+426
| +9% | +$45.5K | ﹤0.01% | 1814 |
|
|
2025
Q1 | $499K | Sell |
4,750
-414
| -8% | -$46.8K | ﹤0.01% | 1873 |
|
|
2024
Q4 | $553K | Sell |
5,164
-394
| -7% | -$44.5K | ﹤0.01% | 1893 |
|
|
2024
Q3 | $556K | Sell |
5,558
-144
| -3% | -$14.5K | ﹤0.01% | 1942 |
|
|
2024
Q2 | $480K | Buy |
5,702
+78
| +1% | +$6.21K | ﹤0.01% | 2025 |
|
|
2024
Q1 | $411K | Sell |
5,624
-1,182
| -17% | -$87.1K | ﹤0.01% | 2106 |
|
|
2023
Q4 | $486K | Buy |
6,806
+75
| +1% | +$4.43K | ﹤0.01% | 2086 |
|
|
2023
Q3 | $403K | Buy |
6,731
+100
| +2% | +$6.58K | ﹤0.01% | 2156 |
|
|
2023
Q2 | $478K | Buy |
6,631
+844
| +15% | +$63.3K | ﹤0.01% | 2109 |
|
|
2023
Q1 | $426K | Hold |
5,787
| – | – | ﹤0.01% | 2137 |
|
|
2022
Q4 | $387K | Sell |
5,787
-3,490
| -38% | -$227K | ﹤0.01% | 2171 |
|
|
2022
Q3 | $498K | Hold |
9,277
| – | – | ﹤0.01% | 2026 |
|
|
2022
Q2 | $516K | Sell |
9,277
-339
| -4% | -$19.2K | ﹤0.01% | 1819 |
|
|
2022
Q1 | $675K | Buy |
9,616
+174
| +2% | +$12.6K | ﹤0.01% | 1731 |
|
|
2021
Q4 | $910K | Sell |
9,442
-5,310
| -36% | -$491K | ﹤0.01% | 1611 |
|
|
2021
Q3 | $1.28M | Sell |
14,752
-172
| -1% | -$13.3K | ﹤0.01% | 1409 |
|
|
2021
Q2 | $1.22M | Sell |
14,924
-587
| -4% | -$48.8K | ﹤0.01% | 1496 |
|
|
2021
Q1 | $1.48M | Buy |
15,511
+250
| +2% | +$23.6K | ﹤0.01% | 1339 |
|
|
2020
Q4 | $947K | Buy |
15,261
+2,552
| +20% | +$145K | ﹤0.01% | 1541 |
|
|
2020
Q3 | $756K | Buy |
12,709
+3,315
| +35% | +$226K | ﹤0.01% | 1441 |
|
|
2020
Q2 | $655K | Sell |
9,394
-4,466
| -32% | -$283K | ﹤0.01% | 1482 |
|
|
2020
Q1 | $629K | Sell |
13,860
-20,893
| -60% | -$1.18M | ﹤0.01% | 1485 |
|
|
2019
Q4 | $2.26M | Sell |
34,753
-43,789
| -56% | -$2.93M | ﹤0.01% | 1050 |
|
|
2019
Q3 | $4.88M | Sell |
78,542
-276,423
| -78% | -$17.4M | 0.01% | 805 |
|
|
2019
Q2 | $25.3M | Buy |
354,965
+21,293
| +6% | +$1.57M | 0.05% | 331 |
|
|
2019
Q1 | $26.2M | Buy |
333,672
+31,138
| +10% | +$2.36M | 0.06% | 297 |
|
|
2018
Q4 | $25.6M | Buy |
302,534
+64,333
| +27% | +$6.86M | 0.06% | 300 |
|
|
2018
Q3 | $40.8M | Buy |
238,201
+1,557
| +0.7% | +$235K | 0.08% | 250 |
|
|
2018
Q2 | $30.6M | Sell |
236,644
-504
| -0.2% | -$56.2K | 0.07% | 327 |
|
|
2018
Q1 | $24.4M | Buy |
237,148
+214,470
| +946% | +$21.2M | 0.05% | 368 |
|
|
2017
Q4 | $1.94M | Sell |
22,678
-238
| -1% | -$20.6K | ﹤0.01% | 1058 |
|
|
2017
Q3 | $1.95M | Sell |
22,916
-312,521
| -93% | -$24.7M | ﹤0.01% | 1052 |
|
|
2017
Q2 | $25.4M | Sell |
335,437
-6,709
| -2% | -$469K | 0.06% | 333 |
|
|
2017
Q1 | $22.6M | Buy |
342,146
+50,897
| +17% | +$3.35M | 0.05% | 352 |
|
|
2016
Q4 | $18.5M | Buy |
291,249
+10,065
| +4% | +$635K | 0.04% | 391 |
|
|
2016
Q3 | $17.9K | Buy |
281,184
+11,523
| +4% | +$846K | 0.03% | 383 |
|
|
2016
Q2 | $20.1M | Buy |
269,661
+250,962
| +1,342% | +$18.6M | 0.05% | 356 |
|
|
2016
Q1 | $1.25M | Buy |
18,699
+5,954
| +47% | +$362K | ﹤0.01% | 1170 |
|
|
2015
Q4 | $862K | Hold |
12,745
| – | – | ﹤0.01% | 1362 |
|
|
2015
Q3 | $681K | Sell |
12,745
-3,014
| -19% | -$183K | ﹤0.01% | 1517 |
|
|
2015
Q2 | $992K | Sell |
15,759
-4,060
| -20% | -$222K | ﹤0.01% | 1434 |
|
|
2015
Q1 | $953K | Sell |
19,819
-1,860
| -9% | -$71.3K | ﹤0.01% | 1484 |
|
|
2014
Q4 | $720K | Hold |
21,679
| – | – | ﹤0.01% | 1677 |
|
|
2014
Q3 | $635K | Hold |
21,679
| – | – | ﹤0.01% | 1737 |
|
|
2014
Q2 | $842K | Sell |
21,679
-1,600
| -7% | -$64.9K | ﹤0.01% | 1614 |
|
|
2014
Q1 | $977K | Hold |
23,279
| – | – | ﹤0.01% | 1487 |
|
|
2013
Q4 | $764K | Hold |
23,279
| – | – | ﹤0.01% | 1643 |
|
|
2013
Q3 | $629K | Hold |
23,279
| – | – | ﹤0.01% | 1728 |
|
|
2013
Q2 | $543K | Buy |
+23,279
| New | +$419K | ﹤0.01% | 1762 |
|
Other funds holding LGND
VPM
VCM
NAMI
CC
VOYA Investment Management's LGND Position: Q1 2026 in Review
VOYA Investment Management reduced its Ligand Pharmaceuticals (LGND) stake by 2.6% in Q1 2026, selling an estimated $18K and leaving 3,356 shares worth $670K. The position accounts for ﹤0.01% of the portfolio, ranked #1608.
VOYA Investment Management first reported a position in LGND in Q2 2013 and has held it in 52 quarters since. The position peaked at $40.8M in Q3 2018. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.
- VOYA Investment Management held 3,356 shares of Ligand Pharmaceuticals worth $670K as of Q1 2026.
- VOYA Investment Management sold 91 Ligand Pharmaceuticals shares in Q1 2026, an estimated $18K.
- Ligand Pharmaceuticals made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #1608 holding.
- VOYA Investment Management first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- VOYA Investment Management's Ligand Pharmaceuticals position peaked at $40.8M in Q3 2018.
- 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.
Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.